Tratamiento de la Sepsis

1) Bernard GR, Vincent J-L, Laterre P-F, et al: "Efficacy and safety of recombinant human activated protein C for severe sepsis". N. Engl. J. Med., 2001; 344: 699-709.

2) Esmon CT: "Introduction: are natural anticoagulans candidates for modulating the inflammatory response to endotoxin?". Blood, 2000; 95: 1113-6.

3) Esmon CT: "Regulation of blood coagulation". Biochim. Biophys. Acta, 2000; 1477: 349-60.

4) Kurahashi K, Kajikawa O, Sawa T, et al: "Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia". J. Clin. Invest., 1999; 104: 743-50.

5) Lorente JA, García Frade LJ, Landin L, et al: "Time course of hemostatic abnormalities in sepsis and its relation to outcome". Chest, 1993; 103: 1536-42.

6) Matthay MA: "Severe Sepsis - A new treatment with both anticoagulant and antiinflammatory properties". N. Engl. J. Med., 2001; 344:

7) Parrillo JE: "Pathogenetic mechanisms of sept